• Wamlox

  Form: tablets, film-coated

  Active substance	Dosage
  amlodipine	5 mg
  valsartan	80 mg

  ATC code: C09DB01

  Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

• Wamlox

  Form: tablets, film-coated

  Active substance	Dosage
  amlodipine	5 mg
  valsartan	160 mg

  ATC code: C09DB01

  Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

• Wamlox

  Form: tablets, film-coated

  Active substance	Dosage
  amlodipine	10 mg
  valsartan	160 mg

  ATC code: C09DB01

  Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

• Wamlox

  Form: tablets, film-coated

  Active substance	Dosage
  Amlodipine	5 mg
  Valsartan	320 mg

  ATC code: C09DB01

  Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

• Wamlox

  Form: tablets, film-coated

  Active substance	Dosage
  amlodipine	10 mg
  valsartan	320 mg

  ATC code: C09DB01

  Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

• Warfarin

  Form: tablets

  Active substance	Dosage
  Sodium warfarin	3 mg

  ATC code: B01AA03

  Manufacturer: Orion Corporation

• Warfarin

  Form: tablets

  Active substance	Dosage
  Sodium warfarin	5 mg

  ATC code: B01AA03

  Manufacturer: Orion Corporation

• Wasedoc

  Form: capsules, hard

  Active substance	Dosage
  dabigatran etexilate	110 mg

  ATC code: B01AE07

  Manufacturer: Terapia S.A., TOWA Pharmaceuticals Europe, S.L.

• Wasedoc

  Form: capsules, hard

  Active substance	Dosage
  dabigatran etexilate	150 mg

  ATC code: B01AE07

  Manufacturer: Terapia S.A., TOWA Pharmaceuticals Europe, S.L.

• Water for injection baxter

  Form: solution for preparation of parenteral drugs

  Active substance	Dosage
  Water for injection	100% w/v

  ATC code: V07AB

  Manufacturer: Baxter Healthcare S.A., Baxter S.A., Bieffe Medital S.A.

• Water for injection polpharma

  Form: solution for preparation of parenteral drugs

  Active substance	Dosage
  Water for injection	No input provided

  ATC code: V07AB

  Manufacturer: Polpharma Pharmaceutical Works S.A.

• Water for injections braun

  Form: solution for preparation of parenteral drugs

  Active substance	Dosage
  Water for injection	No input provided

  ATC code: V07AB

  Manufacturer: B. Braun Medical S.A., B. Braun Melsungen AG

• Water for injections csl behring

  Form: solution for preparation of parenteral drugs

  Active substance	Dosage
  Water for injection	No input provided

  ATC code: V07AB

  Manufacturer: CSL Behring GmbH

• Welbox

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: Balkanpharma Dupnitsa AD Genericon Pharma Ges.m.b.H.

• Welbox

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: +pharma arzneimittel GmbH

• Welbox

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: +pharma arzneimittel GmbH

• Welbox

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: +pharma arzneimittel GmbH

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Monoprosopi A.E.B.E.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline, S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Monoprosopi A.E.B.E.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline – Produtos Farmacêuticos, Ltd.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Pharma GmbH

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Pharmaceuticals S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline BV

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Pharma GmbH

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline, S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Pharmaceuticals S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline – Produtos Farmacêuticos, Ltd.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline (Ireland) Limited

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: BIAL - Portela & Ca. S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: BIAL - Portela & Ca. S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	150 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline, S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline, S.A.

• Wellbutrin xr

  Form: tablets, modified release

  Active substance	Dosage
  bupropion hydrochloride	300 mg

  ATC code: N06AX12

  Manufacturer: GlaxoSmithKline Trading Services Limited

• Wilate 1000

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor VIII	1000 j.m.
  von Willebrand factor human	1000 j.m.

  ATC code: B02BD06

  Manufacturer: Octapharma GmbH

• Wilate 500

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  human coagulation factor VIII	500 j.m.
  von Willebrand factor human	500 j.m.

  ATC code: B02BD06

  Manufacturer: Octapharma GmbH

• Willfact 1000 j.m.

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  von Willebrand factor human	1000 j.m.

  ATC code: B02BD10

  Manufacturer: LFB-Biomedicaments

• Willfact 2000 j.m.

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  von Willebrand factor human	2000 j.m.

  ATC code: B02BD10

  Manufacturer: LFB-Biomedicaments

• Willfact 500 j.m.

  Form: solution for injection, powder and solvent for preparation of

  Active substance	Dosage
  von Willebrand factor human	500 j.m.

  ATC code: B02BD10

  Manufacturer: LFB-Biomedicaments

• Wynzora

  Form: cream

  Active substance	Dosage
  calcipotriol	50 mcg/g
  betamethasone dipropionate	0.644 mg/g

  ATC code: D05AX52

  Manufacturer: Laboratoires Chemineau